Market Research Logo

Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2012-2018

Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2012-2018

The Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2012-2018 report provides comprehensive understanding and unprecedented access to the joint venture deals and agreements entered into by the worlds leading life science companies.

This report provides details of the latest joint venture agreements announced in the pharmaceutical, biotechnology and diagnostic sectors. Fully up to date, the report provides details of joint venture agreements from 2012.

There is an increasing willingness for parties to enter joint venture deals; such deals enable both parties to benefit from the upside of a big product win, whereas traditional licensing deals forfeit upside for near term upfront, milestone and royalty payments.

Joint venture partnering allow the parties to securitize value and reduce risk, but keep a part of the potential upside should the product reach the market. Event if the licensor does not commercialize the project they can either sell those rights to the licensee partner or another partner for an amount higher than would have been achieved at an earlier stage licensing deal.

Another reason for joint venture deals is the joint origin of a project. Drug development projects often require various scientific and technological novelties that stem from different companies. If both companies contributed to the origination of the project, then both have from the beginning a stake in the project.

The report provides a detailed understanding and analysis of how and why companies enter joint venture deals.

Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases do not.

This report contains a comprehensive listing of all joint venture deals announced since 2012 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual joint venture contract documents as submitted to the Securities Exchange Commission by companies and their partners.

Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal.

The initial chapters of this report provide an orientation of joint venture dealmaking and business activities. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an analysis of the trends in joint venture as well as a discussion on the merits of the type of deal.

Chapter 3 provides an overview of the structure of joint venture deals. The chapter includes numerous case studies to enable understanding of joint venture deals.

Chapter 4 provides a review of the leading Joint venture deals since 2012. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.

Chapter 5 provides a comprehensive listing of the top 50 most active Joint venture dealmaker companies. Each deal title links via Current Agreements deals and alliances database to an online version of the full deal record, and where available, the actual contract document, providing easy access to each deal record on demand.

Chapter 6 provides a comprehensive and detailed review of Joint venture deals organized by company A-Z, therapy, technology and industry type signed and announced since 2012 where a contract document is available. Contract documents provide an indepth insight into the actual deal terms agreed between the parties with respect to the Joint venture deal.

The appendices to the report includes a comprehensive listing of all Joint venture deals announced since 2012. Each listing is organized as an appendix by company A-Z, stage of development at signing, therapeutic area and industry type. Each deal title links via hyperlink to an online version of the deal record including, where available, the actual contract document.

The report also includes numerous table and figures that illustrate the trends and activities in Joint venture dealmaking since 2012.

In conclusion, this report provides everything a prospective dealmaker needs to know about Joint venture alliances.

Key benefits

Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2012-2018 provides the reader with the following key benefits:

In-depth understanding of joint venture partnering deal trends since 2012
Analysis of the structure of joint venture agreements with numerous real life case studies
Comprehensive listing of all joint venture deals since 2012, together with deal terms, value and press release
Comprehensive access to actual joint venture contracts entered into by the world’s life science companies
Insight into the terms included in a joint venture agreement, together with real world clause examples
Understand the key deal terms companies have agreed in previous deals
Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Report scope

Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2012-2018 is intended to provide the reader with an in-depth understanding of the joint venture trends and structure of deals entered into by leading life science companies worldwide.

Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2012-2018 includes:

Trends in joint venture dealmaking in the biopharma industry since 2012
Analysis of joint venture deal structure
Case studies of real-life joint venture deals
Comprehensive listing of joint venture deals since 2012
Access to joint venture contract documents
The leading joint venture deals by value since 2012
Most active joint venture dealmakers since 2012
The leading joint venture partnering resources

In Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2012-2018 available deals and contracts are listed by:

Company A-Z
Headline value
Therapeutic area
Technology type

Each deal title links via Weblink to an online version of the actual deal record and where available, contract document, providing easy access to each contract document on demand.

The Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2012-2018 report provides comprehensive access to available contract documents for joint venture deals. Analyzing actual contract agreements allows assessment of the following:

What are the precise rights granted or optioned?
What is actually granted by the agreement to the partner company?
What exclusivity is granted?
What is the payment structure for the deal?
How do milestone align with clinical stage development phases?
How are salesand payments audited?
What is the deal term?
How are the key terms of the agreement defined?
How are IPRs handled and owned?
Who is responsible for commercialization?
Who is responsible for development, supply, and manufacture?
How is confidentiality and publication managed?
How are disputes to be resolved?
Under what conditions can the deal be terminated?
What happens when there is a change of ownership?
What sublicensing and subcontracting provisions have been agreed?
Which boilerplate clauses does the company insist upon?
Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
Which jurisdiction does the company insist upon for agreement law?


  • Executive Summary
  • Introduction
  • Trends in joint venture partnerships
    • Introduction
    • Definition of joint venture deals
      • Table Definition of joint venture
    • Success factors for joint venture partnerships
    • When joint venture partnerships can be useful
    • Attributes of joint venture partnerships
      • Table Key components of a joint venture partnership
    • Aligning partners to make the joint venture work
      • Table Issues in implementing joint venture partnership agreements
    • Trends in joint venture partnerships since 2012
      • Joint venture dealmaking by year, 2012 to 2018
      • Joint venture dealmaking by stage of development 2012 to 2018
      • Joint venture dealmaking by industry sector 2012 to 2018
      • Joint venture dealmaking by therapy area, 2012 to 2018
      • Joint venture dealmaking by technology type, 2012 to 2018
      • Joint venture dealmaking by most active company, 2012 to 2018
    • The future of joint venture partnerships
  • Overview of joint venture deal structure
    • Introduction
      • Table Joint venture shareholder agreements - what should a contract include?
    • Joint venture agreement structure
      • Table Components of the joint venture deal structure
    • Example joint venture agreements
      • Agila Specialties - Pfenex
      • Dance Biopharm - Harmony Asset
  • Leading joint venture deals
    • Introduction
    • Top joint venture deals by value
      • Table Top joint venture deals by value since 2012
  • Top 50 most active active joint venture dealmakers
    • Introduction
    • Top 50 most active joint venture dealmakers
      • GlaxoSmithKline
      • AstraZeneca
      • Mayo Clinic
      • Bristol-Myers Squibb
      • Fosun Pharmaceutical
      • MedQuest
      • Abbott Laboratories
      • Astellas Pharma
      • Boehringer Ingelheim
      • Helomics
      • Pfizer
      • Sanofi
      • Takeda Pharmaceutical
      • Teva Pharmaceutical Industries
      • 3SBio
      • Amgen
      • Genome Institute of Singapore
      • Histogen
      • Johnson & Johnson
      • Merck and Co
      • Neovacs
      • Pfenex
      • Pluristem Therapeutics
      • Rainbow BioSciences
      • Sanuwave Health
  • Joint venture deals including contracts directory
    • Introduction
    • Joint venture deals with contracts 2012 to 2018
  • Appendices
    • Joint venture dealmaking by companies A-Z
      • 3SBio
      • AAP Implantate AG
      • Abbott Laboratories
      • Abbvie
      • Abdi Ibrahim
      • Abdi Ibrahim Otsuka Pharmaceutical
      • Abilita Bio
      • ABIVAX
      • Abzena
      • Acharya NG Ranga Agricultural University
      • Actavis (acquired by Watson)
      • Advanced Technologies Solutions
      • Advocate Health Care
      • AD Biotech
      • Aequus Pharmaceuticals
      • Agalimmune
      • Agila Specialties
      • Agilent Technologies
      • Agilis Biotherapeutics
      • AirWare Labs
      • Aitbiotech
      • Akers Biosciences
      • Alliance Healthcare Services
      • Allied-Bristol Life Sciences
      • Allied Minds
      • Allscripts
      • Alpharmagen
      • Alpha Szenszor
      • AltrazealTrading
      • Alzheimer's Association
      • Amarantus BioSciences
      • Amendia
      • American CryoStem
      • American Diabetes Association
      • Amerigen Pharmaceuticals
      • AmerisourceBergen
      • Amgen-Beta Pharmaceuticals
      • Amgen
      • Amgen Astellas BioPharma
      • Amunix
      • Amyris Brazil
      • AnaBios
      • Anhui Wisdom-Win Investment
      • Animatrix Capital
      • Anokion
      • Antisense Therapeutics
      • Antitope
      • Anvyl
      • Apax Partners
      • Apollo Hospitals Group
      • Arcadia Biosciences
      • Ascendance Biotechnology
      • Asia Glycomics Education Center
      • ASKLEP
      • Asklepios Biopharmaceutical
      • Assay Depot
      • Astellas Pharma
      • AstraZeneca
      • Athenahealth
      • Athenex
      • Atrium Innovations
      • Aurobindo Pharma
      • Autogenesis
      • AUT Roche Diagnostics Laboratory
      • AUT University
      • Avalon Ventures
      • Avanti Specialty Pharmacy Management
      • Avvinity Therapeutics
      • Bacterial Robotics
      • Banner Health
      • BASF
      • Baxter International
      • Bayer
      • Bayer Healthcare
      • Baylor College of Medicine
      • Baylor Health Care System
      • Baylor Miraca Genetics Laboratories
      • BCG Oncology
      • Becton Dickinson
      • Beijing Genomics Institute (BGI)
      • Beijing Leadman Biochemistry
      • Beijing Origin Seed
      • Beta Renewables
      • BGI Tech Solutions
      • Bio-XCell
      • BioAmber
      • BioBay
      • Bioceres
      • Biodist
      • Biogen
      • BioHeart
      • Biohit
      • Biohit Biotech
      • Biohit Healthcare
      • BioLife Solutions
      • BioLight
      • BiolineRX
      • BioLinQ
      • Biological E
      • Biologistex CCM
      • BioMed X Innovation Center
      • BioPharma Services
      • BioTime
      • Bioton
      • Bloomage BioTechnology
      • Bloom Burton
      • Blue Cross Blue Shield Association
      • Blue Cross Blue Shield of Arizona Advantage
      • Boehringer Ingelheim
      • Breakaway Policy Strategies
      • Breckenridge Pharmaceuticals
      • Bristol-Myers Squibb
      • Broncus Medical
      • Broncus Technologies
      • Buchang Pharmaceutical
      • B Braun
      • B Braun CeGaT
      • Caliber Biotherapeutics
      • Cancer Genetics
      • Cancer Research Technology
      • Cannabis Science
      • Cannabis Therapeutics
      • CannaRoyalty
      • CanTX
      • Capnia
      • Capstone Therapeutics
      • Cardio3 Biosciences Asia Holdings
      • Casebia Therapeutics
      • Catalent Pharma Solutions
      • Catapult Therapy TCR
      • CDF Dinova Venture Partners
      • Cedar Gate Technologies
      • CeGaT
      • Celerion
      • Cell Therapy
      • Cell Therapy Catapult
      • Celyad
      • Centauri Therapeutics
      • Center for Cancer Research
      • Center for Cancer Research Exchange
      • Center for Genetic Engineering and Biotechnology (Cuba)
      • Centre for Commercialization of Regenerative Medicine (CCRM)
      • Centre for Drug Design and Discovery
      • Centre for Drug Research and Development (CDRD)
      • Cerner
      • Changshan Biochemical Pharma
      • CHA Bio & Diostech
      • Chi-Med
      • Chiesi Farmaceutici
      • Children's Medical Research Institute
      • Chimera Biotec
      • China Grand Pharma
      • Chinese Academy of Science
      • Chinese Future Industry Investment Fund
      • Chongqing PSK-Health Sci-tech Development
      • Chungnam National University
      • Cimym
      • City of Hope
      • CJ CheilJedang
      • ClearPath
      • Cleveland Clinic
      • Cloaked Therapeutics
      • Co-Diagnostics
      • Co-Diagnostics HBDC
      • Cohen Veterans Bioscience
      • Cold Spring Harbor
      • Colibri Heart Valve
      • Collagen Solutions Plc
      • Columbus Venture Partners
      • CoMentis
      • CommonWell Health Alliance
      • Community Health Systems
      • Compugen
      • Concord Biosciences
      • Concord Medical Services Holdings
      • ConjuChem Biotechnologies
      • CoreRx Pharma
      • Corestone Biosciences
      • Corning
      • Cre8ive
      • Create Vaccine Company
      • CRISPR Therapeutics
      • CureCell
      • CytoBioscience
      • DaAn Gene
      • Daiichi Sankyo
      • Dainippon Sumitomo Pharma
      • Dalian Wanchun
      • Dana-Farber Cancer Institute
      • Dance Biopharm
      • Dasman Diabetes Institute
      • David H. Koch Institute for Integrative Cancer Research
      • David Snow
      • DaVita
      • DaVita Taiwan
      • Defyrus
      • Demetra
      • Denka-KEW Genomics
      • Denka
      • DepYmed
      • Diamed Medizintechnik GmbH
      • DIAN Diagnostics
      • DiaSorin
      • DiaSorin Trivitron Healthcare
      • Diavax Biosciences
      • Dignity Health
      • Dimension Therapeutics
      • Dizal Pharmaceutical
      • DNA Logix
      • Doctors Optimal Formula
      • Domain Associates
      • Domain Elite
      • Dongbao
      • DPx Holdings
      • Dr. Walter Bell
      • Dr Charles Hensley
      • DSM
      • DSM Pharmaceutical Products
      • Duke-NUS Graduate Medical School Singapore
      • Dupetit Natural Products
      • Eastar Industries
      • Eastern Capital
      • Easton Pharmaceuticals
      • ECardio Diagnostics
      • Eddingpharm
      • Elanix Biotechnologies
      • Elite Consulting
      • Eli Lilly
      • EMD Millipore
      • EMD Serono
      • Emory Healthcare
      • Engage:BDR
      • Enigma Diagnostics
      • Enzymotec
      • ERS Genomics
      • Essential Molecular Testing
      • Ethica Industri Farmasi
      • ExCellThera
      • ExitCare
      • Facebook
      • Faes Farma
      • Fidelity Biosciences
      • FJ Pharma
      • Flagship Ventures
      • Flexpoint Ford
      • Fluidigm
      • Fonterra
      • Food and Drug Administration (FDA)
      • Foresee Pharmaceuticals
      • FORMA Therapeutics
      • Fortress Biotech
      • Fosun Pharmaceutical
      • Fox Chase Cancer Center
      • Fraunhofer Institute for Microelectronic Circuits and Systems
      • Freedom Leaf
      • Fresenius Kabi Pharmaceuticals
      • Frontage Laboratories
      • Fujifilm
      • Fujifilm Kyowa Kirin Biologics
      • G-treeBNT
      • Galectin Sciences
      • Galectin Therapeutics
      • Galvani Bioelectronics
      • Gauss Surgical
      • GB Oncology & Imaging Group
      • GeneNews
      • Genentech
      • Gene Therapy Research Institution
      • Genomatica
      • Genome Institute of Singapore
      • Gentag
      • Gentiva Health Services
      • GeoVax
      • Gerresheimer
      • Ghent University
      • GHO Capital
      • Ginkgo BioWorks
      • GlaxoSmithKline
      • GLG Pharma
      • Government of South Africa
      • Government Pharmaceutical Organization
      • Greenway Medical Technologies
      • GTCR Golder Rauner
      • Hainan Savy Akers Biosciences
      • Hainan Savy Investment Management
      • Hammer Institute for Health Sciences
      • Handok Pharmaceuticals
      • Hanna Instruments
      • Hao Capital
      • HardTech Labs
      • Harmony Asset
      • Harvard Eye Associates
      • HealthPartners Institute for Education and Research
      • Health Discovery
      • Heidelberg Engineering
      • Helomics
      • Henan Agricultural University
      • Hepregen
      • Hetero India
      • Hi-Tech Pharmaceuticals
      • HighRes Biosolutions
      • HikmaCure
      • Hikma Pharmaceuticals
      • Hillhouse Capital Group
      • Hisamitsu Pharmaceutical
      • Histogen
      • Histogen Oncology
      • Hisun-Pfizer Pharmaceuticals
      • Horizon Discovery
      • Horizon Pharma plc
      • Hospital of University of Strasbourg
      • HuangShi Feiyun Pharma
      • HUYA Bioscience
      • HVIVO
      • I-Bridge Capital
      • IBA
      • IBA Molecular Imaging
      • IBio
      • ICAN
      • Ideal Concept Group
      • Iluminage
      • Iluminage Beauty
      • ImaginAb
      • IMD Companies
      • ImmuneOncia
      • ImmunGene
      • IMPak Health
      • Imperial College London
      • Imperial Innovations
      • Imutex
      • Inception 4
      • Inception 5
      • Inception Sciences
      • Indegene Lifesystems
      • Index Ventures
      • Infinity Group
      • InnoCentive
      • InnoKeys
      • InnoMab
      • Innovata HK
      • Innovation Network Corporation
      • Institute for Research in Immunology and Cancer - Commercialization of Research
      • Institut Pasteur of Shanghai at the Chinese Academy of Sciences
      • Intas Biopharmaceuticals
      • Intercytex
      • International Crops Research Institute for the Semi-Arid Tropics
      • International Genomics Consortium
      • International Medical Center
      • Intrexon
      • Intuitive Surgical
      • InVentiv Health
      • Isomerase Therapeutics
      • Israel Structural Proteomics Center
      • Itonis
      • Itonis Pharmaceuticals
      • Japan Vaccine
      • JLL Partners
      • Johnson & Johnson
      • Johnson & Johnson Innovation
      • Juvenile Diabetes Research Foundation
      • Kangmei Pharma
      • Kanyos
      • Karolinska Development
      • Kastle Therapeutics
      • Keensight Capital
      • Kennedy Health System
      • KEW
      • Kineta
      • Kineta RLB
      • Kite Pharma
      • KLOX Technologies
      • Korea Kolmar
      • KPI Therapeutics
      • Kubota Pharmaceutical
      • Kuwait Life Sciences
      • Kyowa Hakko Kirin
      • LabCentral
      • La Jolla Institute for Allergy & Immunology
      • Lead Discovery Center
      • Lee Moffitt Cancer Center
      • LEO Pharma
      • LFB Biotechnologies
      • LHP Hospital Group
      • LifeArc
      • LifeTech Scientific
      • Life Chemicals
      • Life Technologies
      • Life Technologies DaAn Diagnostics
      • Lipimetix
      • LipimetiX Development
      • Living Proof
      • Lonza
      • Loxbridge Research
      • Lupin
      • Lupin Pharmaceuticals
      • Lupus Foundation of America (LFA)
      • Lyra Health
      • Maccura Biotechnology
      • Magellan Health Services
      • Magellan of Arizona
      • Magnum Cell Therapies
      • Malaghan Institute
      • Mapp Biopharmaceutical
      • MaSTherCell
      • Mayo Clinic
      • McKesson
      • McLean Hospital
      • MDxHealth
      • Mead Johnson Nutrition
      • Medical Implant Solutions
      • Medical Marketing Economics
      • Medifocus
      • MedImmune
      • Medipal Holdings
      • Medisun International
      • MedQuest
      • Medtronic
      • Medybloom
      • Medytox
      • Mehlman Vogel Castagnetti
      • Melmed
      • MemorialCare Health System
      • Memorial Sloan Kettering Cancer Center
      • Merck and Co
      • Merck Research Ventures Fund
      • Merck Serono
      • Metro Medical Supply
      • Mettler Toledo
      • MicroPort Scientific
      • MicroPort Sorin CRM (Shanghai)
      • MicuRx Pharmaceuticals
      • MidaSol Therapeutics
      • Midatech
      • MIDROC Pharmaceuticals
      • Milestone Advanced Cosmetic Systems
      • Milestone China
      • Milestone Scientific
      • Miraca
      • Mitsubishi Chemical Corporation
      • Molnlycke Health Care
      • MonoSolRx
      • MPI Research
      • Mundimed
      • Music Saves Lives
      • MVI Health
      • Mylan Laboratories
      • Mylan Pharmaceuticals
      • N3D Biosciences
      • Nakashima
      • NantPharma
      • NantPro BioSciences
      • NantWorks
      • National Bureau of Plant Genetic Resources
      • National Cancer Institute
      • National Institutes of Health
      • Nationwide Children's Hospital
      • Naton Medical
      • NatureWorks
      • Navidea Biopharmaceuticals
      • Nemaura Medical
      • Neomed Institute
      • Neopharma
      • Neostell
      • Neovacs
      • NephCure Kidney International
      • Neptune Technologies & Bioressources
      • Nestle
      • NetScientific
      • NeuroVive Pharmaceutical
      • Neviah Genomics
      • New York Genome Center (NYGC)
      • Nexgen Pharma
      • NHS Bio
      • Nicox
      • Nisarga Biotech
      • Nordic Bioscience
      • Norgine
      • North Mississippi Health Services
      • Novant Health
      • Novartis
      • Noviosense
      • Novogen
      • Novogene
      • Novozymes
      • NT Pharma
      • NuAxon BioScience
      • NXTGNT
      • Ocimum Biosolutions
      • Ohr Pharmaceuticals
      • Olympus
      • OncoQuest
      • OncoSpire Genomics
      • OncoVent
      • Oncurious
      • Optasia Medical
      • Optum
      • Optum Labs
      • Orchid Chemicals and Pharma
      • Orchid Medical
      • Orgenesis
      • Origin Agritech
      • OSA Niaga
      • Otsuka
      • OvaScience
      • OvaXon
      • Oxford MEstar
      • Oxis International
      • Pamlab
      • Pantarhei Bioscience
      • Paradigm
      • Penumbra
      • PerkinElmer
      • Petronas Chemicals Group
      • Pfenex
      • Pfizer
      • PGXL Partners
      • PGXL Technologies
      • PharmaPraxis
      • Pharmascience
      • Pharmascience Korea
      • Philips
      • Phoenix Health Plan
      • Phynexus
      • Piedmont Healthcare
      • Pieris
      • Pittsburgh Life Sciences Greenhouse
      • PlantForm
      • Pluristem Therapeutics
      • Polar Omega
      • Polytherics
      • PPD
      • PRA Health Sciences
      • Premier Biomedical
      • Prestwick Chemical
      • Preventice
      • Preventice Inc
      • Procter & Gamble
      • Profarma
      • Prometic Life Sciences
      • Promimic
      • ProQinase
      • Protein Genomics
      • Provectus Biopharmaceuticals
      • Provision Asia
      • Purdue Pharma
      • PureTech Ventures
      • PUR Biologics
      • Q2 Solutions
      • Qiagen
      • QIAGEN (Suzhou) Translational Medicine Center
      • QPS
      • QPS Hepatic Biosciences
      • Quebec Government
      • Quest Diagnostics
      • Quest PharmaTech
      • Quintiles
      • R-NAV
      • RadNet
      • Rainbow BioSciences
      • Ranbaxy Laboratories
      • Ranbaxy Pharmaceuticals
      • Redbiotec
      • Regenerx
      • ReGenX Biosciences
      • RelayHealth
      • Reliable Medical
      • ReproCell
      • Research Pharmaceutical Services
      • Respiratory Motion
      • Retinalyze
      • Rheumco
      • Riches Healthcare
      • RLB Holdings
      • Rochal Industries
      • Roche
      • Roche Diagnostics
      • Rock-One International
      • Rockefeller University
      • Romulus Titan
      • Royal Philips Electronics
      • RSV
      • Rusnano
      • Sacred Heart Health System
      • Salk Institute
      • Samsung Bioepis
      • Sanara Ventures
      • Sancor Cooperativas Unidas
      • Sandler-Kenner Foundation
      • Sanofi-Aventis
      • Sanofi-Hisamitsu
      • Sanofi-Pasteur
      • Sanofi
      • Sanuwave Health
      • Saromics
      • SAVSU Technologies
      • SBH Sciences
      • SBI Capital Markets
      • Scentryphar
      • Sciex
      • ScinoPharm Taiwan
      • Scohia Pharma
      • Scripps Research Institute
      • Secondary Military Medical University
      • Seegene
      • SEEK
      • SeQuent Scientific
      • Shanghai Biochip Company
      • Shanghai Chonghe Marine Industry
      • Shanghai MengKe Pharmaceuticals
      • Shanghai Pharmaceutical
      • Shanghai Pharmaceuticals Greater Health Online Company
      • Shanghai Zhangjiang Biomedical Industry Venture Capital
      • ShangPharma
      • Shared Clarity
      • Shasun Pharmaceuticals
      • Shenzhen Hepalink Pharmaceutical
      • Shenzhen Neptunus Interlong Bio-Technique
      • Shin Nippon Biomedical Laboratories
      • Shin Poong Pharmaceutical
      • SiMCare Diabetes
      • Sinopharm
      • Sirona Biochem
      • Sitari Pharmaceuticals
      • Sixense Enterprises
      • Skyline Medical
      • SK Capital Partners
      • Smart Medicines GMP
      • SOHO Group
      • Soleno Therapeutics
      • Sonacare Medical
      • Sony
      • Sony Olympus Medical Solutions
      • Sorin Group
      • Sorrento Therapeutics
      • Sosei
      • SpePharm
      • Spepharm Holding
      • Stanford University
      • Steep Hills Labs
      • Stelis Biopharma
      • Stellar Biotechnologies
      • Straits Orthopedics
      • Strides Arcolab
      • SunGen
      • Sun Pharmaceutical
      • Supera Farma Laboratorios
      • Synbiotics
      • Syneron Beauty
      • Syneron Medical
      • Synlogic
      • Sysmex
      • S K Wu Corn Research Institute
      • Takeda Pharmaceutical
      • Tasly Pharmaceuticals
      • Tauriga Sciences
      • TCL Medical
      • Technion Research and Development Foundation
      • Tecres
      • Teijin
      • Teijin Nakashima Medical
      • Temasek Polytechnic
      • TeselaGen
      • TesoRx Pharma
      • Teva Pharmaceutical Industries
      • Themes Investment Partners
      • Therakine
      • ThromboGenics
      • Tianjin Institute of Pharmaceutical Research
      • Tianjin International Joint Academy of Biotechnology and Medicine (TJAB)
      • Tianjin KingYork
      • Tianjin Kinnovata
      • Tianyin Pharmaceutical
      • TIPR-HUYA Advancing Innovative Medicines
      • Titian Software
      • TLC Laser Eye Centers
      • TNI BioTech
      • TNK Therapeutics
      • Tonghua Dongbao Pharma
      • Total Gas & Power USA Biotech
      • TransCelerate BioPharma
      • TranScrip
      • Transformatix Technologies
      • Transgene
      • Transgene Tasly Biopharmaceutical
      • Translational Kinase Tumor Inhibitor Discovery Consortium
      • Tri-Institutional Therapeutics Discovery Institute
      • Tririver Capital
      • Trius Therapeutics
      • Triventis
      • Trivitron Healthcare
      • Truffle Capital
      • UCL Business
      • Uluru
      • Unigene Laboratories
      • Unilever Ventures
      • UnitedHealthcare
      • United States Agency for International Development
      • University City Science Center
      • University College London
      • University Hospital South Manchester
      • University of Agricultural Sciences
      • University of Alabama at Birmingham
      • University of Cambridge
      • University of Maryland
      • University of Michigan
      • University of Minnesota
      • University of Turin
      • Uteron Pharma
      • Valeant Pharmaceuticals
      • Valorem Surgical
      • Valorem Surgical AP
      • Valor Biotherapeutics
      • Vancouver Prostate Centre
      • Vasomedical
      • Vectura
      • Velocity Pharmaceutical Development
      • Venus Medtech
      • Venus Remedies
      • Verdeca
      • Verily
      • Versant Ventures
      • Versartis
      • Very Important Donor Club
      • ViaMune
      • VIB
      • Viralgen
      • VitalSims
      • Vitesse Biologics
      • Vivere Health
      • VIWA Pharmaceutical
      • VSK Medical
      • Vyaire Medical
      • Vyripharm
      • WaferGen Biosystems
      • Wake Forest University Baptist Medical Center
      • WardMM
      • Weill Cornell Medical College
      • WellStar Health System
      • Wexford Science & Technology
      • Wirthlin-Denton
      • Wuxi Apptec Laboratory Services
      • WuXi PharmaTech
      • Wylde
      • X-chem
      • Xpress Technologies
      • Yale University
      • YL Biologics
      • Yongyi Biotechnology
      • Yongyi Hi-Tech Nutraceuticals
      • Yoshindo
      • Yuhan Corporation
      • Zhangjiang Biotech & Pharmaceutical Base Development Company
      • Zhaotai Group
      • Zhejiang Beta Pharma
      • Zhejiang Hisun Pharmaceutical
      • Zhejiang Jiuzhou Pharmaceutical
      • Zhongxie Pharma
      • Zhongyuan Union Stem Cell Bioengineering
      • Zydus Cadila
    • Joint venture dealmaking by industry sector
      • Academic
      • Agricultural
      • Animal Health
      • Bigbiotech
      • Bigpharma
      • Biotech
      • Consumer health
      • Drug delivery
      • Medical device
      • Diagnostic
      • Financial
      • Generic pharma
      • Government
      • Non-profit
      • Pharmaceutical
      • Research tools
      • Services
      • Specialty pharma
    • Joint venture dealmaking by stage of development
      • Discovery
      • Preclinical
      • Phase I
      • Phase II
      • Phase III
      • Regulatory
      • Marketed
      • Formulation
    • Joint venture dealmaking by therapy area
      • Anaesthetics
      • Cardiovascular
      • Congenital heart disease
      • Coronary artery disease
      • Hypercholesterolemia
      • Limb ischemia
      • Peripheral arterial disease
      • Central Nervous System
      • Headache
      • Multiple sclerosis
      • Pain
      • Parkinson's disease
      • Spinal cord
      • Stroke
      • Traumatic Brain Injury
      • Dental
      • Xerostomia
      • Dermatology
      • Acne
      • Cosmetics
      • Dermatitis
      • Diabetic foot ulcer
      • Psoriasis
      • Wound healing
      • Wrinkles
      • Gastrointestinal
      • Celiac disease
      • Crohn's disease
      • Ulcerative colitis
      • Pancreatitis
      • Genetic disorders
      • Rare genetic disorders
      • Genitourinary
      • Diabetic nephropathy
      • Prostate enlargement
      • Renal failure
      • Gynaecology
      • Infertility
      • Hematology
      • Anemia
      • Hemophilia
      • Hospital care
      • Accident and emergency
      • Surgery
      • Aesthetic procedures
      • Orthopedics
      • Immunology
      • AIDS
      • Allergy
      • Other autoimmune
      • Inflammation
      • Systemic lupus erythematosus
      • Infectives
      • Bacterial
      • Diphtheria
      • Methicillin-resistant Staphylococcus aureus (MRSA)
      • Tetanus
      • Tuberculosis (TB)
      • Viral
      • Cytomegalovirus
      • Ebola
      • B
      • C
      • Herpes simplex
      • HIV
      • Influenza
      • Polio
      • Respiratory syncytial virus (RSV)
      • Zika
      • Metabolic
      • Diabetes
      • Type 1
      • Type 2
      • Growth hormone disorders
      • Liver disease
      • Nutrition and vitamins
      • Musculoskeletal
      • Arthritis
      • Ankylosing spondylitis
      • Osteoarthritis
      • Rheumatoid arthritis
      • Back pain
      • Osteoporosis
      • Oncology
      • Bladder cancer
      • Brain cancer
      • Breast cancer
      • Cervical cancer
      • Colorectal cancer
      • Gastric cancer
      • Head and neck cancer
      • Kidney cancer
      • Leukemia
      • Acute lymphoblastic leukemia
      • Lung cancer
      • Lymphoma
      • Non Hodgkin's lymphoma
      • Melanoma
      • Metastases
      • Multiple myeloma
      • Ovarian cancer
      • Pancreatic cancer
      • Prostate cancer
      • Solid tumors
      • Cancer pain
      • Ophthalmics
      • Age-related macular degeneration
      • Blindness
      • Diabetic macular edema
      • Dry eye
      • Glaucoma
      • Retinopathy
      • Diabetic retinopathy
      • Orphan disease
      • Pediatrics
      • Psychiatry
      • Alzheimers
      • Schizophrenia
      • Drugs
      • Respiratory
      • Asthma
      • Chronic obstructive pulmonary disease
      • Nasal congestation
      • Sexual Health
      • Contraception
    • Joint venture dealmaking by technology type
      • Analysis
      • Animal models
      • Antibiotics
      • Antibodies
      • Antibody-drug conjugate
      • Bispecific antibodies
      • Monoclonal antibodies
      • Humanized mAb
      • Human mAb
      • Assays
      • Bioinformatics
      • Biological compounds
      • Biomarkers
      • Biomaterials
      • Bioprocessing
      • Biosimilars/Bio-betters
      • Blood products
      • Cell culture
      • Clinical testing
      • CRISPR
      • Devices
      • Surgical robotics
      • Diagnostics
      • Companion
      • Imaging
      • CT
      • MRI
      • PET (Positron Emission Tomography)
      • X-ray
      • Mammography
      • In vitro diagnostics
      • Molecular diagnostics
      • Discovery tools
      • High throughput screening (HTS)
      • Drug delivery
      • Implantable
      • Oral delivery
      • Delayed release
      • Infusion
      • Injectable
      • Transdermal
      • Transmucosal
      • Buccal
      • Inhaled
      • Enabling technology
      • Enviromental
      • Epigenetics
      • Equipment
      • Facilities
      • Gene therapy
      • Genomics
      • Glycomics
      • Implant
      • Industrial chemicals
      • In vitro models
      • Nanotechnology
      • Natural product
      • Peptides
      • Personalised medicine
      • Pharmacogenomics
      • Probiotics
      • Processes
      • Proteomics
      • Radio/Chemo-therapy
      • Recombinant DNA
      • Regenerative medicine
      • Cell therapy
      • Stem cells
      • Tissue regeneration
      • Research services
      • Research supplies
      • RNA therapeutics
      • Screening
      • Small molecules
      • Software tools
      • Toxicity
      • Transgenics
      • Vaccines
      • Conjugate vaccine
      • DNA vaccine
    • Joint venture references
    • Resources
      • Table Online partnering resources
    • Deal type definitions
      • Table Deal type definitions
  • About Wildwood Ventures
    • Current Partnering
    • Current Agreements
    • Recent report titles from Current Partnering

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report